Margareta P Correia

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Endoplasmic Reticulum Stress

Dna Methylation

Prostate Cancer

Epidermal Growth Factor Receptor

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Catarina Guimarães-Teixeira, João Lobo, Vera Miranda-Gonçalves, Daniela Barros-Silva, Cláudia Martins-Lima, Sara Monteiro-Reis, José Pedro Sequeira, Isa Carneiro, Margareta P Correia, Rui M Henrique, Carmen Jerónimo
Downregulation of m 6 A writer complex member METTL14 in bladder urothelial carcinoma suppresses tumor aggressiveness. Molecular oncology 16 (9) (2022)
Mariana Brütt Pacheco, Vânia Camilo, Nair Lopes, Filipa Moreira-Silva, Margareta P Correia, Rui M Henrique, Carmen Jerónimo
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines. Pharmaceuticals (Basel, Switzerland) 14 (7) (2021)
Matthias Bozza, Alice De Roia, Margareta P Correia, Aileen Berger, Alexandra Tuch, Andreas Schmidt, Inka Zörnig, Dirk Jäger, Patrick Schmidt, Richard P Harbottle
A nonviral, nonintegrating DNA nanovector platform for the safe, rapid, and persistent manufacture of recombinant T cells. Science advances 7 (16) (2021)
Nair Lopes, Mariana Brütt Pacheco, Diana Soares-Fernandes, Margareta P Correia, Vânia Camilo, Rui M Henrique, Carmen Jerónimo
Hydralazine and Enzalutamide: Synergistic Partners against Prostate Cancer. Biomedicines 9 (8) (2021)
Bianca de Cássia Troncarelli Flores, Margareta P Correia, José G Rodríguez, Rui M Henrique, Carmen Jerónimo
Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer. Cancers 13 (16) (2021)
Margareta P Correia, Ana Stojanovic, Winfried S Wels, Adelheid Cerwenka
Innate-like NKp30 + CD8 + T cells armed with TCR/CAR target tumor heterogeneity. Oncoimmunology 10 (1) (2021)
Gonçalo Outeiro-Pinho, Daniela Barros-Silva, Margareta P Correia, Rui M Henrique, Carmen Jerónimo
Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs. Cancers 12 (8) (2020)